Evidence map›Paper›PMID 36255677›Full record

ArticleAdvances in neurobiology2023

Neurological Consequences of Congenital Disorders of Glycosylation.

Justyna Paprocka

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in neurobiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A biallelic variant inLife science alliance · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Justyna PaprockaDepartment of Pediatric Neurology, Faculty of Medical Sciences, Medical University of Silesia, Katowice, Poland. justyna.paprocka@interia.pl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The chapter is devoted to neurological aspects of congenital disorders of glycosylation (CDG). At the beginning, the various types of CDG with neurological presentation of symptoms are summarized. Then, the occurrence of various neurological constellation of abnormalities (for example: epilepsy, brain anomalies on neuroimaging, ataxia, stroke-like episodes, autistic features) in different CDG types are discussed followed by data on possible biomarkers and limited treatment options.

Indexed as

Congenital Disorders of GlycosylationEpilepsyBiomarkersGlycosylationHumansBiomarkersBiochemical markersBrain abnormalitiesCongenital disorders of glycosylationGlycosphingolipidsGlycosylphosphatidylinositol anchor synthesisNeurological presentationN-linked glycosylationO-linked glycosylation

Identifiers

PMID36255677

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.